baber/WOPTO huggingface dataset:
Patent NZ-321150-A (NZ)
Title: Oxygen-permeable multilayer film containing antifog agent, packaging process using same, and packaged product comprising same
Inventor: KUO BETSY P
IPC: B65D30/08
Filed: 1996-10-15
Abstract: A multi-layer film includes a first outer layer comprising at least one of ethylene homopolymer, ethylene/alpha-olefin copolymer, ethylene/ester copolymer, ethylene /acid copolymer and ionomer, and a surface active component of at least one of aliphatic alcohol, polyether, polyhydric alcohol, ester of polyhydric alcohol, and polyethoxylated aromatic alcohol, the surface active layer being present over the entire outside surface of the first outer layer. The film includes an inner layer of a polyolefin  and a second outer layer of the similar materials of the first outer layer but without the surface active component. The multi-layer film has an O2-transmission rate of from 500 to 50,000 cc/m2.24hr STP and 0% humidity. A proviso is that at least one of the first and second outer layers comprises a homogenous ethylene/alpha-olefin copolymer. Also disclosed is a packaging process using the film and a product packaged in the film. The film is especially suitable for the packaging of oxygen-sensitive products, such as lettuce, and resists fogging on the inside surface of the film forming the package. Preferably, the package has printing on the outside surface of the film, with the print having good adhesion to the film.
Patent NZ-330887-A (NZ)
Title: Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
Inventor: FRUDAKIS TONY N
IPC: C12Q1/68
Filed: 1997-01-10
Abstract: Compositions and methods for the detection and therapy of breast cancer are disclosed. The compounds provided include nucleotide sequences that are preferentially expressed in breast tumor tissue, as well as polypeptides encoded by such nucleotide sequences. Vaccines and pharmaceutical compositions comprising such compounds are also provided and may be used, for example, for the prevention and treatment of breast cancer. The polypeptides may also be used for the production of antibodies, which are useful for diagnosing and monitoring the progression of breast cancer in a patient.
Patent NZ-331829-A (NZ)
Title: Clostridium perfringens vaccines
Inventor: TITBALL RICHARD WILLIAM
IPC: C12N15/00
Filed: 1997-03-11
Abstract: A polypeptide capable of producing an immune response which is protective against Clostridium perfringens the peptide comprising an amino acid sequence with 70% homology with the amino acid sequence of Clostridium perfringens epsilon toxin as shown in Seq. ID No 2 in the specification or an immunogenic fragment thereof, characterised in that the amino acid residue corresponding to residue 106 of the mature toxin is of an amino acid other than histidine. Further claimed is the nucleic acid comprising the polypeptide and part of Seq. ID No 5 and 6, expression vector, cell transformed by the vector, process for making the polypeptide, vaccine comprising the polypeptide, and a plasmid comprising recombinant DNA of the polypeptide.
Patent NZ-332082-A (NZ)
Title: Method and apparatus for treating concrete blocks to provide a textured surface by use of a flail
Inventor: CASTONGUAY BERTIN
IPC: B28B11/08
Filed: 1998-09-28
Abstract: n apparatus for treating selected at least partial surface of masonry block is claimed.  A flail mean 70 & 72 has a shaft 74 & 75 with an axis of rotation in a vertical plane.  The apparatus has at least a moving means 38 & 40 for moving one of the masonry blocks parallel to the vertical plane and the fail means.  The apparatus also has means for holding 44 & 46 (upper conveyors) the masonry blocks with the selected surface to be treated at a distance from the shaft to be impacted by the flail means.  A method of treating a selected at least partial surface of a masonry block is also claimed.
Patent NZ-332172-A (NZ)
Title: Anti-caries oral composition containing a synergistic combination of calcium, arginine and a cariostatic anion
Inventor: KLEINBERG ISRAEL
IPC: A61K31/6615
Filed: 1997-03-04
Abstract: The specification describes cariostatic oral compositions which contain therapeutic amounts of calcium, arginine and a cariostatic anion. These compounds may interact to form an anti-caries complexand thus alleviate many of the problems associated with current therapies for preventing dental caries.
Patent NZ-334062-A (NZ)
Title: Producing a synchronous drive belt from a multi-plied belt band built around an internal drum mould having adjacent right and left hand rings with teeth-forming grooves therein
Inventor: GREGG MICHAEL JOHN WILLIAM
IPC: B29C33/02
Filed: 1996-08-22
Abstract: A method of producing a synchronous drive belt having teeth extending from a belt surface includes the steps of building a multi-plied belt band around an internal drum mould, curing the belt band, and segmenting the cured belt band into belt widths.  The method includes assembling  the drum mould.  The mould has a first set of concentric moulding rings 28 comprising adjacent left and right hand rings 30, 32 having teeth-forming grooves 34A, 34B therein.  The grooves are separated by a predetermined pitch.  The belt band is segmented into belt widths while the band is positioned on the drum mould.  The belt widths are removed from the drum mould by sliding the right hand ring away from the belt width in a first direction and sliding the left hand ring away from the belt width in a second direction.  The drum mould may comprise more than one ring set 28 and successive ring sets 28 may be separated by centre blank rings 36 which act as spacers.
Patent NZ-502802-A (NZ)
Title: Method for removing phosphorus and oxyanion solid sewage pollutants by contacting material with Group IIIB and Group IVB elements
Inventor: DOUGLAS GRANT BRIAN
IPC: B09C1/08
Filed: 1997-12-30
Abstract: A material and method for removal of environmental oxyanions (and especially phosphates), the material comprising a substrate such as a clay modified with complexing elements selected from Group IIIB, Group IVB, and lanthanide elements (or a mixture of such elements). The resultant modified substrate can bind oxyanions and make them unavailable for utilisation in the environment; in the case of phosphates, by algae and the like. The method includes forming a capping of material at the sediment/water interface, applying the material in the form of pellets at the sediment/water interface, or injecting the pellets into the sediment.
Patent NZ-503618-A (NZ)
Title: Polyol formulation and method of preparing a polyurethane foam using the formulation
Inventor: ZARKA PHILIPPE ETIENNE
IPC: C08L71/02
Filed: 1998-10-21
Abstract: A polyol formulation comprising 20 to 65 wt.% of polyol of a first type forming a miscible mixture with 35 to 80 wt.% of polyol of a second type.  The first type polyol has an average molecular weight of greater than 800, a hydroxyl value of less than 200 mg KOH/g and an ethylene oxide content of less than 75 wt.%.  The second type polyol has an average molecular weight of less than 1000, a hydroxyl value of greater than 300 mg KOH/g and an amine content (expressed in terms of the percentage of N) of at least 0.2 wt.%. The formulation is useful for preparing a semi-flexible polyurethane foam having a softening temperature of 120 °C or more, which may be used in insulating pipes.
Patent NZ-509034-A (NZ)
Title: Extended release oral bilayer dosage composition comprising a layer of desloratadine and a layer of pseudoephedrine
Inventor: CHO WING-KEE PHILIP
IPC: A61K47/12
Filed: 2000-12-20
Abstract: A compressed bilayer solid composition comprises: a) a first layer of an anti-allergic effective amount of desloratadine and a desloratadine protecting amount of a pharmaceutically water insoluble basic calcium, magnesium or aluminum salt or a desloratadine protective amount of at least one pharmaceutically acceptable antioxidant and b) a second layer comprising an effective amount of pseudoephedrine or a salt thereof and a pharmaceutically acceptable excipient and optionally a desloratadine protective amount of at least one pharmaceutically acceptable antioxidant.
Patent NZ-510670-A (NZ)
Title: Top supported device for handling a patient with upper and lower frame portions connected by intermediate frame allowing relative vertical movement between upper and lower frame portions
Inventor: VEST JAN ERIK
IPC: A61G5/14
Filed: 2001-03-22
Abstract: The device is suspended from top mounting 51,52 which in turn supports upper frame 1. The letter supports lower frame 2 having feet and knee supports 6,7. An intermediate linkage 3 connects frames 1,2 so that these frames are relatively movable vertically.
Patent NZ-512027-A (NZ)
Title: Dispersible compositions containing L-dopa ethyl ester
Inventor: LEVIN GALIT
IPC: A61K31/135
Filed: 1999-11-10
Abstract: A dispersible tablet comprising: L-DOPA ethyl ester (25 to 50% by weight), a decarboxylase inhibitor (3 to 10% by weight), a micorcrystalline cellulose (35 to 60% by weight), a starch and a lubricant ( 0.5 to 6% by weight).
Patent NZ-514782-A (NZ)
Title: Drinking fountain faucet
Inventor: MCCORMICK DONALD IAN PATRICK
IPC: E03B9/20
Filed: 2001-10-15
Abstract: A drinking fountain faucet that has a push button, a cover shield, and a valve portion having a recessed water outlet.
Patent NZ-522549-A (NZ)
Title: Brake device for a lift
Inventor: SIMMONDS OLIVER
IPC: B66B5/22
Filed: 2001-05-23
Abstract: Disclosed is a brake device (6), acting upon a guide rail (2) and comprising a housing (9) arranged on the yoke (4, 5), which serves as support for spring assemblies (10) and/or for adjustment assemblies (11). The housing (9) also serves as support and guide for V-guide elements (12), which in turn fix and guide brake wedges (13) with brake linings (14). Connecting rods (15) are connected at one end to the brake wedges (13) and are connected at the other to an operating fork (8.2). During braking, the operating fork (8.2) is displaced at the connecting rod end in the direction of the braking device (6). The guided brake wedges (13) with brake linings (14) slide in the brake device (6). At the same time the brake linings (14) are moved onto the guide web (2.1) of the guide rail (2). The brake wedges (13) are moved in the brake device (6) and the spring- and adjuster-assemblies (10, 11) are put under load, which generates a braking force for stopping of a lift cabin or a counterweight.
Patent NZ-525484-A (NZ)
Title: Using extensible markup language to create word processing documents that can be manipulated by XML enabled applications
Inventor: JONES BRIAN M
IPC: G06F40/00
Filed: 2003-04-24
Abstract: A computer-readable medium having computer-executable components comprises a first component for reading a word-processor document stored as a single XML file; a second component that utilizes an XSD (XML Schema Definition) for interpreting the word-processor document, and a third component for performing an action on the word-processor document. The computer readable medium can further comprise a validating component configured to validate the word-processor document or a fourth component for displaying the word-processor document. The XSD represents a word-processor's rich formatting and the XSD is published and is available to applications other than the word-processor. The word-processor document can include hints to applications that understand XML. The action may be selected from parsing, modifying, reading, and creating the word-processor document and may be fully recreating the word-processor document according to a word processor's set of features.
Patent NZ-530591-A (NZ)
Title: Coal-based organic growth compound as a plant fertiliser
Inventor: JOHNSTON ROBERT J
IPC: C05F11/02
Filed: 2001-11-28
Abstract: A bio-degradable plant growth composition is disclosed, which consists of coal particulate, sodium molybdate, linear alcohol alkoxylate (such as an ethoxylated dodecyl alcohol or a polyethylene oxide ether of C12-C15 primary alcohols), magnesium sulphate, sand or other filler and water.
Patent NZ-531901-A (NZ)
Title: Angiopoietin-2 specific binding agents
Inventor: OLINER JOHNATHAN DANIEL
IPC: A61P35/02
Filed: 2002-10-11
Abstract: Disclosed herein is a specific binding agent comprising at least one complimentarity-determining region (CDR) region selected from the group CDR1, CDR2, and CDR3, wherein CDR1 comprises amino acids 26-36 of SEQ ID NO: 11 or amino acids 23-40 of SEQ ID NO: 12; CDR 2 comprises amino acids 50-66 of SEQ ID NO: 11 or amino acids 54-62 of SEQ ID NO: 12; and CDR3 comprises amino acids 96-112 of SEQ ID NO:11 or amino acids 93-102 of SEQ ID NO: 12, or a fragment thereof having specific binding activity for angiopoietin-2 (Ang-2). Also disclosed is a method making said specific binding agent that comprises: (a) transforming a host cell with at least one nucleic acid molecule encoding said specific binding agent; (b) exposing the nucleic acid molecule in said host cell; and (c) isolating said specific binding agent.
Patent NZ-532868-A (NZ)
Title: Vehicle braking warning apparatus
Inventor: ANDREWS STEWART GRANT
IPC: B60Q1/44
Filed: 2004-05-11
Abstract: An electrical operated vehicle deceleration warning device is disclosed. The warning device includes a deceleration sensor (5) which is coupled into the circuitry of a vehicles rear hazard/indicator lights. The circuitry includes triggering means (9) which is activated by the change in the forces of momentum acting upon, and detected by, the deceleration sensor (5), caused by deceleration changes in the vehicles speed. Activation occurs at a first deceleration threshold predetermined and set within the device (9), resulting in the device (9) sending a signal to the rear hazard/indicator lights of the vehicle to cause the light(s) to illuminate for a first predetermined period. Calibration means is included in the device to enable the sensor to be zeroed when mounted in situ.
Patent NZ-534080-A (NZ)
Title: Vegetation pruning device with chainsaw type cutting element incorporated into shears, with gearing between handles and shearing parts
Inventor: BARKER DAVID
IPC: A01G3/033
Filed: 2004-07-13
Abstract: A vegetation pruning device comprises a pair of arms (not shown) adapted to pivot relative to each other about an axis to adjust the angle between them, and at least one handle portion (not shown) adapted to be gripped by a user. The device also includes a motor having a rotary output drive and an endless flexible cutting element 108 mounted to a first arm, which is driven by the rotary output drive. At least one gripping member is adapted to be moved relative to the cutting element by means of pivoting the arms relative to each other to grip vegetation between the gripping member and the cutting element. A gear mechanism is connected between at least one gripping member and at least one of the arms, wherein pivoting of the arms through a first angle relative to each other causes pivoting of the gripping member and the support through a second angle, larger than the first angle, relative to each other.
Patent NZ-539986-A (NZ)
Title: Novel substance FKI-1033 and process for producing the same
Inventor: OMURA SATOSHI
IPC: A61P43/00
Filed: 2002-11-12
Abstract: A microorganism capable producing a substance FKI-1033 represented by the following formula (I) is cultured in a medium to accumulate the FKI-1033 in the culture medium and then the FKI-1033 is collected from the culture medium. Because of having ryanodine antagonism activity, insecticidal activity and anti-parasitic worm activity, the thus obtained FKI-1033 is expected as being useful as a chemical having satisfactory efficaciousness, toxicity and being applicable to pesticides, veterinary medicines and medicines.
Patent NZ-540637-A (NZ)
Title: Tympanic thermometer with ejection mechanism
Inventor: LANTZ LOREN
Filed: 2003-01-06
Abstract: A tympanic thermometer is provided including a heat sensing probe (22) that defines a longitudinal axis and an outer surface extending from a distal end (24) of the tympanic thermometer. An ejection apparatus including at least one finger (28) extends from the distal end of the tympanic thermometer and is configured for movement along the outer surface of the probe. A probe cover (32) is mountable to the distal end of the tympanic thermometer. The probe cover defines an inner surface configured to engage the outer surface of the probe. The probe cover includes at least one longitudinal rib (36) radially projecting from the inner surface thereof. The longitudinal rib defines a proximal face such that the at least one finger is configured to engage the proximal face. The probe cover can include a plurality of longitudinal ribs.
Patent NZ-548481-A (NZ)
Title: Repetitive cycle tool logic and mode indicator for combustion powered fastener-driving tool
Inventor: DOHERTY JAMES E
IPC: B25C1/08
Filed: 2005-01-31
Abstract: A combustion-powered fastener-driving tool (10) includes a combustion-powered power source (14), a workpiece contact element (32) reciprocable relative to the power source (14) between a rest position and a firing position, a control system (67) operationally associated with the power source, a trigger (26) connected to the control system (67) providing operator interface with the control system (67). The control system (67) is configured so that an operator may select between a sequential firing mode in which the trigger (26) must be released between firings, and a repetitive cycle mode in which the trigger is continually depressed between firings. The trigger (26) is connected to the control system (67) so that at least one of the frequency and duration of pulling of the trigger (26) converts the operating mode from the sequential mode to the repetitive cycle mode.
Patent NZ-556631-A (NZ)
Title: 1-(Beta-D-glucopyranosyl)-indole derivatives
Inventor: NOMURA SUMIHIRO
IPC: C07D405/14
Filed: 2006-01-31
Abstract: Disclosed are 1-(b-D-glucopyranosyl)-indole derivatives as represented by the formula (I), wherein R1 is halogen or alkyl; R2 is hydrogen, or halogen, and Ar is selected from an optionally substituted phenyl or thiophenyl moiety. Also disclosed is a pharmaceutical composition comprising a compound as defined above and a pharmaceutically acceptable carrier or diluent, and which may further comprise another antidiabetic agent. Further disclosed is the use of a compound as defined above in the manufacture of a medicament for use in the treatment of disorders selected from diabetes mellitus, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, delayed wound healing, insulin resistance, hyperglycemia, hyperinsulinemia, elevated blood levels of fatty acids, elevated blood levels of glycerol, hyperlipidemia, obesity, hypertriglyceridemia, Syndrome X, diabetic complications, atherosclerosis, and hypertension.
Patent NZ-560832-A (NZ)
Title: Carrying rack with pivotal upright portion and pivotal lateral portions
Inventor: CLARIDGE DAVID ALISTAIR
IPC: B60R9/06
Filed: 2007-08-22
Abstract: A carrying rack, typically for bicycles, is disclosed having at least one support member for supporting at least one object to be carried and at least one upright member attached to the support member(s) at an upper end and to a vehicle at a lower end. The support member(s) is foldable about a horizontal axis only from a use position transverse to the upright member to a non-use position where there is alignment with the support and upright members. Additionally the upright member is reversibly tiltable away from the vehicle to a non-use position while the upright member is attached to the vehicle.
Patent NZ-564045-A (NZ)
Title: Stable fixed-dose formulations containing a combination of antivirals (emtricitabine and tenofovir DF), method for producing thereof using dry granulation
Inventor: DAHL TERRENCE C
IPC: A61K9/16
Filed: 2006-06-13
Abstract: Disclosed is a method comprising dry granulating a compositions comprising a pharmaceutically acceptable excipient, emtricitabine and tenofovir DF to produce dry granules. Also disclosed is a dry granulated composition comprising greater than about 75% by weight emtricitabine and tenofovir DF, and which contains less than about 15% by weight of a eutectic mixture of emtricitabine and tenofovir DF. Further disclosed is the use of the dry granulated composition for the manufacture of a medicament for antiviral therapy in particular anti-HIV therapy.
Patent NZ-568108-A (NZ)
Title: Compositions and methods for modulating hemostasis
Inventor: CAMIRE RODNEY M
IPC: A61K38/36
Filed: 2006-11-15
Abstract: Provided is a Factor Xa variant which modulates haemostasis comprising at least one substitution mutation at an amino acid selected from the group consisting of: a) the Ile at position 16 in chymotrypsin numbering system, b) the Val at position 17 in chymotrypsin numbering system, c) the Gly at position 18 in chymotrypsin numbering system, d) the Gly at position 19 in chymotrypsin numbering system, and e) the Asp at position 194 in chymotrypsin numbering system, wherein if only the Ile at position 16 is changed, the residue is not substituted with Ala or Val. Further provided are corresponding nucleic acids encoding the peptide variants. The compounds can be used to treat haemostasis-related disorders.
Patent NZ-569105-A (NZ)
Title: A method for the expansion of tumor-reactive CD4 positive T-helper and CD positive T-lymphocytes
Inventor: WINQVIST OLA
IPC: C12N5/07
Filed: 2006-12-20
Abstract: An in vitro method for the expansion of tumour-reactive CD4 positive T helper and/or CD8 positive T-lymphocytes comprising two phases. The first phase comprises stimulating the cells with tumour-derived antigen and an IL-2 receptor agonist to promote survival of the cells. The second phase comprises activating and promoting the growth of the cells. The second phase is initiated when the CD25 surface marker is down-regulated on the cells, wherein down-regulated is defined as 5% or less of the T-lymphocyte population express CD25. The second phase is initiated by the addition of the tumour-derived antigen to the T-lymphocytes for activating tumour-reactive CD25-negative T-lymphocytes.
Patent NZ-569880-A (NZ)
Title: Improvements in and relating to particulate retention
Inventor: STEEL KENNETH
IPC: E02D17/20
Filed: 2008-07-14
Abstract: A step mould framework 1000 for a path step or steps on sloping ground includes a pair of sidewalls 100 tapering from one end to the other which are laid with one edge 102 on the sloping ground and a connecting wall 200 joining across the broad ends of the sidewalls. Stones or earth may be put into the space 8 defined between the sidewalls and the connecting wall to form a step of a path. The connecting wall may be provided with apertures to drain water whilst retaining the earth or stones.
Patent NZ-571300-A (NZ)
Title: Antibodies that bind human protein tyrosine phosphatase beta (HPTPBeta) and uses thereof
Inventor: ROTELLO ROCCO JAMIE
IPC: C07K16/40
Filed: 2007-04-05
Abstract: Disclosed is an isolated antibody or antigen-binding fragment thereof which binds to human protein tyrosine phosphatase beta (HPTPB), wherein said antibody or antigen-binding fragment thereof regulates angiogenesis. Also disclosed is the use of the said antibody in the manufacture of a medicament for treating an angiogenesis related disorder.
Patent NZ-572702-A (NZ)
Title: Process for preparing spray dried formulations of etravirine in microcrystalline cellulose
Inventor: KIEKENS FILIP RENE IRENE
IPC: C07D239/48
Filed: 2007-06-06
Abstract: Disclosed is a process for producing a solid pharmaceutical powder, comprising the steps of: (a) providing a feed mixture of microcrystalline cellulose and a solution of a water-soluble polymer and TMC125 (also known as 4-[6-amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile, Etravirine or R165335), which is represented by the formula (1); and (b) spray-drying the feed mixture from step (a) to form a solid dispersion of TMC125 and the polymer by introducing the feed mixture as droplets into a spray-drying chamber via an atomizing means. Also disclosed is a solid dispersion of TMC125 in powder form, which comprises TMC125, microcrystalline cellulose and a water-soluble polymer (such as hydroxypropylmethyl cellulose, polyvinyl pyrrolidone, and copolyvidone).